Home
News
Your Voice
Links
Jobs
Sitemap
Contact
YOU ARE HERE: >
Kernow Clinical Commissioning Group
>
Formulary Information
>
Information Page
Home
Drugs
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Chapters
KCC Referral
Management System
Shared Care
Guidelines
Care Home
Resources
Local Resource
Packs
Chronic Pain
in Cornwall
Diabetes Resources
Respiratory Resources
Flu Resource Pack
Patient Group Direction (PGD)
Palliative Care Resources
Search
Search Drugs
Search BNF Categories
Notes
Click to View ALL BNF
Ch1 Gastro
Ch2 Cardio
Ch3 Respiratory
Ch4 CNS
Ch5 Infections
Ch6 Endocrine
Ch7 Obs & Gynae
Ch8 Malignant Disease
Ch9 Nutrition & Blood
Ch10 Muscuskeletal
Ch11 Eye
Ch12 Ear, Nose, Oropharynx
Ch13 Skin
Ch14 Immunological
Ch15 Anaesthesia
Ch19 Other Dugs
ch20 Dressings
ch21 Appliances
ch22 Incontinence appliances
ch23 Stoma appliances
>>
1. Positive Inotropic Drugs
2. Diuretics
3. Anti-Arrhythmic Drugs
4. Beta-Adrenoceptor Blocking Drugs
5. Hypertension and Heart Failure
6. Nit,Calc Block & Other Antianginal Drugs
7. Sympathomimetics
8. Anticoagulants And Protamine
9. Antiplatelet Drugs
10. Stable angina, acute coronary syndromes, and fibrinolysis
11. Antifibrinolytic Drugs & Haemostatics
12. Lipid-Regulating Drugs
13. Local Sclerosants
>>
0. Lipid-Regulating Drugs
(Click to View Drug List)
Cost
Cost
Packs
Packs
Items
Items
Loading…
Summary:
Formulary Notes (BNF Chapter)
Formulary Notes (BNF Chapter)
Formulary Notes (BNF Section)
Formulary Notes (BNF Section)
NICE Guidance (13)
NICE Guidance (13)
Other Links (4)
Other Links (4)
Important Local Documents (5)
Important Local Documents (5)
Notes for: Cardiovascular system
Last edited [20/01/2023 09:54:16]
Primary care guidance for the prescribing and supply of Inclisiran
Inclisiran for the treatment of familial or non-familial hyperlipidaemia in secondary prevention of CVD
Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD
NHS South West
Strategic Clinical Network - Top tips for managing AF
Clinical
guidelines for Secondary Prevention
after Stroke or TIA
Commissioning recommendations for national procurement for DOACs
Notes for: Lipid-Regulating Drugs
Last edited [12/08/2021 10:11:04]
NICE Guidance (BNF Section Level) for - Lipid-Regulating Drugs
07/08/2014
CG181 - Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease
15/09/2016
TA393 - Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
15/09/2016
TA394 - Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
13/05/2021
TA694 Bempedoic acid with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemia
12/10/2021
TA733 Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia
05/09/2022
TA805 Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides
NICE Guidance (BNF Chapter Level) for - Cardiovascular system
11/12/2020
NICE guideline [NG185] Acute coronary syndromes
22/11/2021
NICE guideline (NG208) Heart valve disease presenting in adults: investigation and management
22/11/2021
NICE guideline (CG187) Acute heart failure: diagnosis and management
16/02/2022
NG196 Atrial fibrillation: diagnosis and management
20/02/2023
Cardiovascular disease: risk assessment and reduction, including lipid modification CG181
17/04/2023
Hypertension in pregnancy: diagnosis and management NG133
17/05/2023
Hypertension in adults: diagnosis and management NG136
Other links (BNF Section Level) for - Lipid-Regulating Drugs
26/09/2016
Rosuvastatin (Crestor): introduction of 5 mg starting dose (MHRA May 2006)
Other Links (BNF Chapter Level) for - Cardiovascular system
16/12/2021
Clinical guidelines for Secondary Prevention after Stroke or TIA
16/02/2022
RCHT Thrombosis Prevention and Anticoagulation Policy 2021
20/01/2023
Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD
Important Local Documents (BNF Section Level) for - Lipid-Regulating Drugs
15/09/2016
CLINICAL GUIDELINE FOR SECONDARY PREVENTION AFTER STROKE OR TIA (PRIMARY AND SECONDARY CARE CORNWALL)
Important Local Documents (BNF Chapter Level) for - Cardiovascular system
10/08/2021
Protocol for the review of people with atrial fibrillation (AF) not receiving an anticoagulant 2021
24/07/2022
Inclisiran for the treatment of familial or non-familial hyperlipidaemia in secondary prevention of CVD
25/07/2022
Primary care guidance for the prescribing and supply of Inclisiran
17/08/2020
NHS South West Strategic Clinical Network - Top tips for managing AF
Loading…
Cornwall Joint Formulary Recommended Choices
(...Top)
Displaying 29 Drugs
Key:
First Line Drugs
Second Line Drugs
Specialist Initiated Drugs
Hospital Only Drugs
Discouraged
No comment available
Antibiotics
Name
Tariff
BNF Sub Paragraph
Atorvastatin
10 mg tab Pack of 28
£0.69
Lipid-Regulating Drugs
Atorvastatin
20 mg tab Pack of 28
£0.92
Lipid-Regulating Drugs
Atorvastatin
40 mg tab Pack of 28
£1.03
Lipid-Regulating Drugs
Atorvastatin
80 mg tab Pack of 28
£1.38
Lipid-Regulating Drugs
Bezafibrate M/R (Bezalip Mono)
400 mg m/r tab Pack of 30
£7.63
Lipid-Regulating Drugs
Icosapent (Vazkepa)
998 mg capsules Pack of 120
£144.21
Lipid-Regulating Drugs
Only for patients already on a statin. Please note increased risk of AF
Simvastatin
10 mg tab Pack of 28
£0.75
Lipid-Regulating Drugs
Simvastatin
20 mg tab Pack of 28
£0.79
Lipid-Regulating Drugs
Rosuvastatin
5 mg tab Pack of 28
£0.91
Lipid-Regulating Drugs
Simvastatin
40 mg tab Pack of 28
£0.93
Lipid-Regulating Drugs
Rosuvastatin
10 mg tab Pack of 28
£1.03
Lipid-Regulating Drugs
Rosuvastatin
20 mg tab Pack of 28
£1.32
Lipid-Regulating Drugs
Simvastatin
80 mg tab Pack of 28
£1.48
Lipid-Regulating Drugs
Rosuvastatin
40 mg tab Pack of 28
£1.70
Lipid-Regulating Drugs
Ezetimibe
10 mg tabs Pack of 28
£1.84
Lipid-Regulating Drugs
Fenofibrate
200 mg cap Pack of 28
£2.99
Lipid-Regulating Drugs
Fenofibrate
267 mg cap Pack of 28
£3.54
Lipid-Regulating Drugs
Fenofibrate
67 mg cap Pack of 90
£23.23
Lipid-Regulating Drugs
Inclisiran
284 mg/1.5ml solution for injection pre-filled syringes Pack of 1
£55.00
Lipid-Regulating Drugs
Bempedoic + Ezetimibe (Nustendi)
180 mg/10mg tablets Pack of 28
£55.44
Lipid-Regulating Drugs
Bempedoic Acid (Nilemdo)
180 mg tabs Pack of 28
£55.44
Lipid-Regulating Drugs
In combination with ezetimibe, for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia or mixed dyslipidaemia in line with NICE TA694.
Colestyramine Powder
4 g oral powder sachets Pack of 50
£10.76
Lipid-Regulating Drugs
Acipimox (Olbetam)
250 mg cap Pack of 90
£46.33
Lipid-Regulating Drugs
Colesevelam
625 mg tablets Pack of 180
£115.32
Lipid-Regulating Drugs
Alirocumab (Praluent)
75 mg/1ml solution for injection pre-filled pen Pack of 1
£168.00
Lipid-Regulating Drugs
Alirocumab (Praluent)
150 mg/1ml solution for injection pre-filled pen Pack of 1
£168.00
Lipid-Regulating Drugs
Evolocumab (Repatha SureClick)
140 mg/1ml solution for injection pre-filled disposable devices Pack of 2
£340.20
Lipid-Regulating Drugs
Atorvastatin
30 mg tab Pack of 28
£24.11
Lipid-Regulating Drugs
Atorvastatin
60 mg tab Pack of 28
£27.49
Lipid-Regulating Drugs
© Kernow Clinical Commissioning Group 2023 - All Rights Reserved
The Sedgemoor Centre, Priory Road, St Austell, Cornwall, PL25 5AS